From crippling fatigue to brain fog, CML treatment can affect your body in ways that go beyond the usual side effects.

Preparations for pivotal-stage readiness of vididencel in AML on trackThe hard work of the Mendus team to advance the company's lead product vididencel in acute myeloid leukemia (AML) continued to pay ...

BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESRE ...

Leukemia cells also live longer than normal cells, build up, and eventually crowd out normal cells in the bone marrow. Chronic leukemias, like CML, grow slower than acute leukemias. Like Kevin, people ...

For patients with previously untreated chronic lymphocytic leukemia (CLL), fixed-duration acalabrutinib-venetoclax wit ...

80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ... Tumor-Induced B Cell ...

In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...

Her medical history was notable for chronic myelomonocytic leukemia, diagnosed 6 years ... Over several months, the patient's symptoms progressed, which resulted in significant weight loss.